Farms.com Home   News

Cool Bean: Consider planting earlier

Research across the Midwest has shown that early-planted soybean have greater yield potential compared to those planted later. The U.S. Department of Agriculture’s Risk Management Agency in 2023 worked with Science for Success Soybean Specialists across the country and shifted the earliest soybean-planting date in states where data was available.

In Wisconsin the date was shifted from April 26 to April 15 in central and southern regions, and to April 20 in the northern part of the state. Consequently within the seven to 11 additional days covered by the Risk Management Agency, some may be suitable for planting if weather permits. The change could allow for planting more acres earlier in the season, thus taking advantage of the yield-increasing effect of early planting.

In Wisconsin we were curious about the potential value the shift could provide to our farmers. Using the USDA-National Agricultural Statistics Service’s data from 2023 on acres planted and total production, we estimated the additional soybean bushels that could be produced by utilizing the extra days suitable for fieldwork – days covered by the new dates. Across the state there were, on average, two additional working days in 2023 – ranging from zero to four depending on the region.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.